Literature DB >> 22930610

Breast conservation in locally advanced breast cancer.

V Parmar, R A Badwe.   

Abstract

Absence of breast cancer screening in India, lack of awareness in rural population, social inhibitions and poor socioeconomic status leads to a situation where a large proportion of women in India are still presenting with locally advanced breast cancer (LABC) at the time of initial diagnosis, although, there are relatively more of early stage cases detected in the metros and urban areas than maybe a decade ago. With advances in care and introduction of newer chemotherapeutic agents, it has now become feasible to offer neoadjuvant therapy with effective tumor downsizing, thus making it possible to even consider breast conservation surgery in select patients with locally advanced and unresectable disease at presentation. With reports suggesting apparent safety of the procedure, breast conservation treatment after chemotherapy is now being offered as routine care in most major centers for selective women with LABC. Multimodality therapy is the standard of care with neoadjuvant systemic therapy for all women with LABC.

Entities:  

Keywords:  Breast conservation; Locally advanced breast cancer; Response; neoadjuvant chemotherapy

Year:  2010        PMID: 22930610      PMCID: PMC3420999          DOI: 10.1007/s13193-010-0003-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  30 in total

1.  Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

Authors:  Davide Mauri; Nicholas Pavlidis; John P A Ioannidis
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

2.  Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.

Authors:  Y Xing; M Foy; D D Cox; H M Kuerer; K K Hunt; J N Cormier
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

3.  Primary chemotherapy and preoperative irradiation for patients with stage II larger than 3 cm or locally advanced non-inflammatory breast cancer.

Authors:  E Touboul; J P Lefranc; J Blondon; L Buffat; E Deniaud; Y Belkacémi; M Benmiloud; J Huart; A Laugier; M Schlienger
Journal:  Radiother Oncol       Date:  1997-03       Impact factor: 6.280

4.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

5.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

6.  Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.

Authors:  Roman Rouzier; Jean-Marc Extra; Jerzy Klijanienko; Marie-Christine Falcou; Bernard Asselain; Anne Vincent-Salomon; Philippe Vielh; Edwige Bourstyn
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel.

Authors:  Ian C Smith; Steven D Heys; Andrew W Hutcheon; Iain D Miller; Simon Payne; Fiona J Gilbert; Antoinne K Ah-See; Oleg Eremin; Leslie G Walker; Tarun K Sarkar; S Peter Eggleton; Keith N Ogston
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

8.  The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Authors:  Amandeep Kumar; Rakesh Kumar; Vathalaru Seenu; Sidharatha Datta Gupta; Madhavi Chawla; Arun Malhotra; Sada Nand Mehta
Journal:  Eur Radiol       Date:  2009-02-13       Impact factor: 5.315

9.  Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

Authors:  Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Mary Jane Oswald; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Fredrick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Naomi R Schechter; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

10.  Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.

Authors:  Delphine Lerouge; Emmanuel Touboul; Jean-Pierre Lefranc; Catherine Genestie; Laurence Moureau-Zabotto; Jean Blondon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

View more
  1 in total

1.  Reconstruction in Breast Conservation Therapy-Single Tertiary Care Institution Experience with 472 Patients.

Authors:  Juhi Agrawal; Sandeep Mehta; Ashish Goel; Veda Padmapriya Selvakumar; Kapil Kumar; Pankaj Kumar Pande
Journal:  Indian J Surg Oncol       Date:  2017-05-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.